Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism prophylaxis: a systematic review of efficacy, safety, and cost-effectiveness. [PDF]
Li B, Zhao L.
europepmc +1 more source
Short-term outcomes of unfractionated heparin vs. low molecular weight heparin in trans-radial coronary angiography: a comparative study. [PDF]
Taha S +4 more
europepmc +1 more source
Predictive model for low-molecular-weight heparin ineffectiveness in pregnant and postpartum women with intracranial venous sinus thrombosis: a multicenter study. [PDF]
Ye X +5 more
europepmc +1 more source
Low-molecular-weight heparin vs aspirin postpartum (LEAP): a single-center pilot randomized control trial. [PDF]
Vlachodimitropoulou E +4 more
europepmc +1 more source
Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case-Control Study. [PDF]
Maglic D +5 more
europepmc +1 more source
Establishment of a bleeding risk model for low-molecular-weight heparin in cancer-associated venous thromboembolism: a single-center retrospective study. [PDF]
Zhang Z, Zhou H, Ren C, Liao L.
europepmc +1 more source
Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy. [PDF]
Zhang X, Ai Z.
europepmc +1 more source
Direct oral anticoagulants compared to low molecular weight heparin for the treatment of venous thromboembolism among individuals with gastrointestinal cancer: an updated meta-analysis. [PDF]
Ren J, Li P.
europepmc +1 more source
Low-molecular-weight heparin alleviates L-arginine-induced acute pancreatitis by modulating lipid metabolism and inflammatory responses in a rat model. [PDF]
Zeng J +5 more
europepmc +1 more source
Early Treatment With Curative Dose Low-Molecular-Weight Heparin (LMWH) Versus Plasmapheresis in Severe Acute Pancreatitis in Intensive Care: A Comparative Study. [PDF]
Yacine A, Mourad O, Soheib Z, Salem H.
europepmc +1 more source

